3,000
Views
35
CrossRef citations to date
0
Altmetric
Research Article

An injectable in situ gel with cubic and hexagonal nanostructures for local treatment of chronic periodontitis

, , , , , , , & show all
Pages 1148-1158 | Received 19 May 2017, Accepted 15 Jul 2017, Published online: 17 Aug 2017

References

  • Bal MV, Olgun A, Abasli D, et al. (2015). The effect of nonsurgical periodontal treatment on serum and saliva chitotriosidase activities in patients with periodontitis and coronary artery disease. Ther Clin Risk Manag 11:53–8.
  • Barat R, Srinatha A, Pandit JK, et al. (2006). Niridazole biodegradable inserts for local long-term treatment of periodontitis: Possible new life for an orphan drug. Drug Deliv 13:365–73.
  • Bruschi ML, Jones DS, Panzeri H, et al. (2007). Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. J Pharm Sci 96:2074–89.
  • Caboi F, Amico GS, Pitzalis P, et al. (2001). Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein/water system. I. Phase behavior. Chem Phys Lipids 109:47–62.
  • Chen X, Wu G, Feng Z, et al. (2016). Advanced biomaterials and their potential applications in the treatment of periodontal disease. Crit Rev Biotechnol 36:760–75.
  • Da Rocha HaJ, Silva CF, Santiago FL, et al. (2015). Local drug delivery systems in the treatment of periodontitis: a literature review. J Int Acad Periodontol 17:82–90.
  • Dabhi MR, Nagori SA, Gohel MC, et al. (2010). Formulation development of smart gel periodontal drug delivery system for local delivery of chemotherapeutic agents with application of experimental design. Drug Deliv 17:520–31.
  • Do MP, Neut C, Delcourt E, et al. (2014). In situ forming implants for periodontitis treatment with improved adhesive properties. Eur J Pharm Biopharm 88:342–50.
  • Do MP, Neut C, Metz H, et al. (2015). In-situ forming composite implants for periodontitis treatment: how the formulation determines system performance. Int J Pharm 486:38–51.
  • Eke P, Dye B, Wei L, et al. (2012). Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 91:914–20.
  • Fong WK, Hanley T, Boyd BJ. (2009). Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo. J Control Release 135:218–26.
  • Gong X, Moghaddam MJ, Sagnella SM, et al. (2011). Lyotropic liquid crystalline self-assembly material behavior and nanoparticulate dispersions of a phytanyl pro-drug analogue of capecitabine-A chemotherapy agent. ACS Appl Mater Interfaces 3:1552–61.
  • Hasturk H, Kantarci A, Ebrahimi N, et al. (2006). Topical H2 antagonist prevents periodontitis in a rabbit model. Infect Immun 74:2402–14.
  • Hau H, Rohanizadeh R, Ghadiri M, Chrzanowski W. (2014). A mini-review on novel intraperiodontal pocket drug delivery materials for the treatment of periodontal diseases. Drug Deliv Transl Res 4:295–301.
  • He J, Zhu X, Qi Z, et al. (2015). Killing dental pathogens using antibacterial graphene oxide. ACS Appl Mater Interfaces 7:5605–11.
  • Joshi D, Garg T, Goyal AK, Rath G. (2016). Advanced drug delivery approaches against periodontitis. Drug Deliv 23:363–77.
  • Kelly HM, Deasy PB, Ziaka E, Claffey N. (2004). Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis. Int J Pharm 274:167–83.
  • Kunieda H, Ozawa K, Huang K-L. (1998). Effect of oil on the surfactant molecular curvatures in liquid crystals. J Phys Chem B 102:831–8.
  • Lee B-S, Lee C-C, Wang Y-P, et al. (2016). Controlled-release of tetracycline and lovastatin by poly (d, l-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs. Int J Nanomed 11:285.
  • Lee J, Young S, Kellaway I. (2001). Water quantitatively induces the mucoadhesion of liquid crystalline phases of glyceryl monooleate. J Pharm Pharmacol 53:629.
  • Li XW, Liu WG, Ye GX, et al. (2005). Thermosensitive N-isopropylacrylamide-N-propylacrylamide-vinyl pyrrolidone terpolymers: synthesis, characterization and preliminary application as embolic agents. Biomaterials 26:7002–11.
  • Mei L, Xie Y, Jing H, et al. (2017). A novel design for stable self-assembly cubosome precursor-microparticles enhancing dissolution of insoluble drugs. Drug Dev Ind Pharm 43:1239–43.
  • Mezzenga R, Schurtenberger P, Burbidge A, Michel M. (2005). Understanding foods as soft materials. Nat Mater 4:729–40.
  • Nasra MMA, Khiri HM, Hazzah HA, Abdallah OY. (2017). Formulation, in-vitro characterization and clinical evaluation of curcumin in-situ gel for treatment of periodontitis. Drug Deliv 24:133–42.
  • Negrini R, Mezzenga R. (2011). pH-responsive lyotropic liquid crystals for controlled drug delivery. Langmuir 27:5296–303.
  • Nguyen S, Hiorth M. (2015). Advanced drug delivery systems for local treatment of the oral cavity. Ther Deliv 6:595–608.
  • Norlen L, Al-Amoudi A. (2004). Stratum corneum keratin structure, function, and formation: the cubic rod-packing and membrane templating model. J Invest Dermatol 123:715–32.
  • Pan X, Han K, Peng X, et al. (2013). Nanostructured cubosomes as advanced drug delivery system. Curr Pharm Des 19:6290–7.
  • Phaechamud T, Mahadlek J, Chuenbarn T. (2016). In situ forming gel comprising bleached shellac loaded with antimicrobial drugs for periodontitis treatment. Mater Des 89:294–303.
  • Poulet PP, Duffaut D, Lodter JP. (1999). Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease. J Clin Periodontol 26:261–3.
  • Qin L, Mei L, Shan Z, et al. (2016). Phytantriol based liquid crystal provide sustained release of anticancer drug as a novel embolic agent. Drug Dev Ind Pharm 42:307–16.
  • Reise M, Wyrwa R, Muller U, et al. (2012). Release of metronidazole from electrospun poly(L-lactide-co-D/L-lactide) fibers for local periodontitis treatment. Dent Mater 28:179–88.
  • Sagalowicz L, Mezzenga R, Leser ME. (2006). Investigating reversed liquid crystalline mesophases. Curr Opin Colloid Interface Sci 11:224–9.
  • Saw CLL, Olivo M, Chin WWL, et al. (2007). Superiority of N-methyl pyrrolidone over albumin with hypericin for fluorescence diagnosis of human bladder cancer cells implanted in the chick chorioallantoic membrane model. J Photochem Photobiol B-Biol 86:207–18.
  • Schwach-Abdellaoui K, Vivien-Castioni N, Gurny R. (2000). Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm 50:83–99.
  • Scriven L. (1976). Equilibrium bicontinuous structure. Nature 263:123–5.
  • Souza C, Watanabe E, Borgheti-Cardoso LN, et al. (2014). Mucoadhesive system formed by liquid crystals for buccal administration of poly (hexamethylene biguanide) hydrochloride. J Pharm Sci 103:3914–23.
  • Srivastava M, Kohli K, Ali M. (2016). Formulation development of novel in situ nanoemulgel (NEG) of ketoprofen for the treatment of periodontitis. Drug Deliv 23:154–66.
  • Van Dyke TE. (2008). The management of inflammation in periodontal disease. J Periodontol 79:1601–8.
  • Wadsater M, Barauskas J, Nylander T, Tiberg F. (2014). Formation of highly structured cubic micellar lipid nanoparticles of soy phosphatidylcholine and glycerol dioleate and their degradation by triacylglycerol lipase. ACS Appl Mater Interfaces 6:7063–9.
  • Warren DB, Anby MU, Hawley A, Boyd BJ. (2011). Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering. Langmuir 27:9528–34.
  • Wibroe PP, Azmi IDM, Nilsson C, et al. (2015). Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriers. Nanomed: Nanotechnol Biol Med 11:1909–14.
  • Yaghmur A, De Campo L, Sagalowicz L, et al. (2005). Emulsified microemulsions and oil-containing liquid crystalline phases. Langmuir 21:569–77.
  • Yaghmur A, De Campo L, Salentinig S, et al. (2006). Oil-loaded monolinolein-based particles with confined inverse discontinuous cubic structure (Fd 3 m). Langmuir 22:517–21.
  • Yaghmur A, Laggner P, Zhang S, Rappolt M. (2007). Tuning curvature and stability of monoolein bilayers by designer lipid-like peptide surfactants. PLoS One 2:e479.
  • Yaghmur A, Larsen SW, Schmitt M, et al. (2011). In situ characterization of lipidic bupivacaine-loaded formulations. Soft Matter 7:8291–5.
  • Yaghmur A, Rappolt M, Ostergaard J, et al. (2012a). Characterization of bupivacaine-loaded formulations based on liquid crystalline phases and microemulsions: the effect of lipid composition. Langmuir 28:2881–9.
  • Yaghmur A, Sartori B, Rappolt M. (2012b). Self-assembled nanostructures of fully hydrated monoelaidin–elaidic acid and monoelaidin–oleic acid systems. Langmuir 28:10105–19.